Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AP-002 in Advanced or Recurrent Solid Tumors
NCT04143789Phase 2Unknown
- Sponsor
- Altum Pharmaceuticals Inc.
- Start
- Sep 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AP-002 in solid tumor, breast cancer, non-small cell lung cancer (NSCLC), prostate cancer (PCa), sponsored by Altum Pharmaceuticals Inc.. Status: unknown.
02
Drugs
AP-002
03
Conditions
solid tumorbreast cancernon-small cell lung cancer (NSCLC)prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04143789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04143789.